Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4167 Health Care Technology

Not Yet Opened 12-22 16:00:00 EST

3,304.56

+32.60

+1.00%

High3,332.11	Low3,270.73	Vol31.42M
Open3,270.77	D1 Closing3,271.96	Amplitude1.88%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O662.98M	T/O Rate--	Tradable Shares0.00
P/B3.533525	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4167","market":"US","secType":"PLATE","nameCN":"Health Care Technology","latestPrice":3304.563,"timestamp":1766437199999,"preClose":3271.9644,"halted":0,"volume":31420581,"delay":0,"changeRate":0.009963,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":32.598633,"latestTime":"12-22 16:00:00 EST","open":3270.765,"high":3332.1106,"low":3270.7253,"amount":662976181.384486,"amplitude":0.018761,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.533525,"peRate":-163.364842,"turnoverRate":0.021591,"increases":16,"decrements":17,"flats":0,"marketCap":64467422598.5,"floatMarketCap":51976263103.25},"requestUrl":"/m/hq/s/BK4167/wiki","defaultTab":"wiki","newsList":[{"id":"2593498487","title":"Phreesia Stock Has Been Crushed. We're Standing By Our Pick. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2593498487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593498487?lang=en_us&edition=fundamental","pubTime":"2025-12-23 16:40","pubTimestamp":1766479200,"startTime":"0","endTime":"0","summary":"Some stocks are hot. Others are cold. Then there's Phreesia.Shares of the healthcare software company have lost nearly half their value in the last four months. Better than expected third quarter earnings on Dec. 8 did nothing to help as the stock plunged 23% on the day.We missed the mark timing Phressia as a Barron's stock pick in August. At the time we cited several tailwinds including solid sales momentum. Efforts to integrate artificial intelligence was part of the bullish thesis.The drop is ugly, but we're not quite ready to let this one go. In our view, the company's growth outlook is still positive. We see Phreesia today and its $1 billion market capitalization positioned to rebound after the surprising valuation reset. Let's unwrap why Phreesia is still a buy for 2026.If there was a culprit for the disappointing market reaction to the earnings report, it was likely guidance for the year ahead. Phreesia issued preliminary fiscal 2027 revenue guidance of $545 million to $559 mill","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","PHR"],"gpt_icon":0},{"id":"2593456793","title":"American Well Director Deborah C. Jackson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593456793","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593456793?lang=en_us&edition=fundamental","pubTime":"2025-12-23 07:39","pubTimestamp":1766446785,"startTime":"0","endTime":"0","summary":"Deborah C. Jackson, Director at American Well Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Well Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL7J4kPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"American Well Director Deborah C. Jackson Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMWL","BK4167"],"gpt_icon":0},{"id":"2593245430","title":"Omnicell (OMCL) valuation check as new Titan XT automation platform targets healthcare growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2593245430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593245430?lang=en_us&edition=fundamental","pubTime":"2025-12-23 02:17","pubTimestamp":1766427476,"startTime":"0","endTime":"0","summary":"Omnicell (OMCL) just rolled out Titan XT, a new enterprise level automated dispensing system built on its OmniSphere cloud platform, and the launch is already reshaping how investors think about the stock.\nSee our latest analysis for Omnicell.\nThe launch of Titan XT coincides with Omnicell’s 30 day share price return of 30.11 percent and 90 day share price return of 51.10 percent, which signal rapidly building momentum. However, the 5 year total shareholder return of negative 60.02 percent...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-omcl-valuation-check-as-new-titan-xt-automation-pla","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-omcl-valuation-check-as-new-titan-xt-automation-pla","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","TWI","BK4167","XT","BK4152","OMCL"],"gpt_icon":0},{"id":"2593363314","title":"OptimizeRx Chief Finance & Strategy Officer Edward Stelmakh Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593363314","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593363314?lang=en_us&edition=fundamental","pubTime":"2025-12-22 23:11","pubTimestamp":1766416275,"startTime":"0","endTime":"0","summary":"Edward Stelmakh, Chief Finance & Strategy Officer of OptimizeRx Corporation, reported a disposal of common shares of OptimizeRx Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL5Nzg5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OptimizeRx Chief Finance & Strategy Officer Edward Stelmakh Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPRX","BK4167"],"gpt_icon":0},{"id":"2593438704","title":"OneMedNet Corporation Outlines 2026 Growth Strategy With Planned Launch of AI-Driven Multimodal Subscription Platform and Enhanced Data Analytics Through Palantir Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2593438704","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593438704?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:00","pubTimestamp":1766412023,"startTime":"0","endTime":"0","summary":"OneMedNet Corporation Outlines 2026 Growth Strategy With Planned Launch of AI-Driven Multimodal Subscription Platform and Enhanced Data Analytics Through Palantir Integration. OneMedNet Corporation has outlined its strategic plan focusing on advancing its platform, supporting its workforce, and executing initiatives to drive growth in 2026. The company plans to leverage Palantir's AI platform  to accelerate the development of its regulatory-grade, AI-ready Real-World Data  network. A key upcoming activity is the planned launch of an AI-driven multimodal subscription search platform in the new year, aimed at enhancing how life sciences organizations access and utilize healthcare data from provider facilities. The strategy emphasizes removing barriers between care providers and researchers, with the goal of reducing time to market for new drugs, medical devices, and healthcare AI solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL5q9PBl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4167","IE00B894F039.SGD","SG9999014039.USD","BK4588","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4613","LU1861559042.SGD","BK4543","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","LU0314104364.USD","LU1861558580.USD","BK4112","BK4023","BK4585","IE00B19Z9P08.USD","IE00B64PRP62.GBP","BK4547","ONMD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2593338354","title":"OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2593338354","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593338354?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:00","pubTimestamp":1766412000,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Dec.  22, 2025  (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator and provider of one of the world's largest regulatory-grade, A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/22/3209276/0/en/OneMedNet-CEO-Aaron-Green-Issues-Letter-to-Shareholders-Highlighting-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4547","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","BK4613","IE00B894F039.SGD","LU1861559042.SGD","BK4167","BK4551","BK4023","LU1861558580.USD","BK4110","BK4587","ONMD","IE00B19Z9P08.USD","BK4528","BK4097","BK4543","BK4081"],"gpt_icon":0},{"id":"2593348026","title":"BRIEF-Scienture Provides Update On The Commercial Launch Of Rezenopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348026","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348026?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:22","pubTimestamp":1766409727,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Provides Update On The Commercial Launch Of RezenopyDec 22 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE PROVIDES UPDATE ON THE COMMERCIAL LAUNCH OF REZENOPY, THE HIGHEST STRENGT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA1DGPVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2593803154","title":"Scienture Holdings Launches High-Strength REZENOPY Naloxone Nasal Spray in U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2593803154","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593803154?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408730,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc. has announced an update on the commercial launch of REZENOPY, a high-strength 10 mg naloxone HCl nasal spray, following its FDA approval in April 2024. Through an exclusive agreement with Summit Biosciences Inc., Scienture will oversee the U.S. commercialization of REZENOPY. The company plans to load the product into wholesale channels in the first quarter of 2026, with commercial availability expected in early Q2 2026. This initiative marks a significant expansion in Scienture’s product portfolio, aiming to address the growing need for effective opioid overdose treatments in the U.S. market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLbp8Fnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4167","SG9999014039.USD","SG9999014013.SGD","BK4112","SG9999014021.USD","NDAQ","SCNX","LU2210149790.SGD","LU0314104364.USD","LU2095319765.USD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4588","BK4585","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2593906480","title":"Scienture Holdings Inc - Rezenopy Expected Commercially Available Early Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593906480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593906480?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA1DGPVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2593480575","title":"SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2593480575","media":"GlobeNewswire","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593480575?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:05","pubTimestamp":1766408700,"startTime":"0","endTime":"0","summary":"U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Dec.  22, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for exist","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/22/3209189/0/en/SCIENTURE-Provides-Update-on-the-Commercial-Launch-of-REZENOPY-the-Highest-Strength-Naloxone-HCl-Life-Saving-Opioid-Overdose-Emergency-Treatment-Approved-by-the-FDA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2593699487","title":"Pheton Holdings Ltd. held annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593699487","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593699487?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:44","pubTimestamp":1766407446,"startTime":"0","endTime":"0","summary":"Pheton Holdings Ltd. held its 2025 Annual General Meeting on December 19, 2025, in Shenzhen, China. Shareholders approved the reelection of Jianfei Zhang and Pengfei Zhang as directors, as well as Swee Leng Seng, Yun Fai Wong, and Richard Wee Yong Seow as independent directors. The auditor's report for the financial year ending December 31, 2024, was approved, ratified, and confirmed. Shareholders also approved a change of the company’s name from \"Pheton Holdings Ltd\" to \"iTonic Holdings Ltd\" and the change of the Nasdaq ticker to \"ITOC,\" \"ITON,\" or \"ITOH.\" An amendment and restatement of the Memorandum and Articles of Association to reflect the name change was approved. The Board of Directors was authorized to effect one or more share consolidations within two years, with an accumulative consolidation ratio of up to 1:4,000, and an amended and restated memorandum and articles of association to effect such share consolidation was also approved, conditional upon the effectiveness of eac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL3lMbM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHL","BK4167"],"gpt_icon":0},{"id":"2593860764","title":"Nutex Health Opens Archview ER & Hospital in St. Louis","url":"https://stock-news.laohu8.com/highlight/detail?id=2593860764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593860764?lang=en_us&edition=fundamental","pubTime":"2025-12-22 18:30","pubTimestamp":1766399411,"startTime":"0","endTime":"0","summary":"Nutex Health Inc., a physician-led integrated healthcare delivery system, has expanded its operations by opening its 26th hospital, Archview ER & Hospital, in St. Louis, Missouri. This marks the company’s first location in the state. The new 16,000 square foot facility features 15 emergency room beds, 3 inpatient suites, a full-service laboratory, and advanced imaging technology, including MRI, CT, X-ray, and ultrasound. Archview ER & Hospital will provide 24/7 concierge-level care to the community, further strengthening Nutex Health’s healthcare footprint across 12 states.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via PR Newswire  on December 22, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLc1kwh3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","BK4185","BK4196","NUTX"],"gpt_icon":0},{"id":"2593455103","title":"Does Veeva Systems’ (VEEV) New Accounting Leadership Deepen Its Governance and Reporting Discipline?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455103?lang=en_us&edition=fundamental","pubTime":"2025-12-22 10:13","pubTimestamp":1766369619,"startTime":"0","endTime":"0","summary":"On December 10, 2025, Veeva Systems’ board appointed long-time finance executive Vipin Kondath as principal accounting officer, formalizing his leadership over the company’s accounting function without changing his existing compensation terms or standard indemnification protections.\nThis promotion, building on Kondath’s years overseeing revenue accounting and serving as corporate controller, highlights Veeva’s emphasis on continuity and experienced oversight in its financial reporting as it...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/does-veeva-systems-veev-new-accounting-leadership-deepen-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/does-veeva-systems-veev-new-accounting-leadership-deepen-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AI","BK4023","VEEV","LU0058720904.USD","BK4585","LU0289739699.SGD","BK4551","BK4613","BK4588","BK4167","BK4528","LU1989764664.SGD","BK4587","BK4543","LU1989764748.USD","LU0170899867.USD","LU0266013472.USD","BK4534","BK4504"],"gpt_icon":0},{"id":"2592118481","title":"Phreesia Inc. President, Network Solutions David Linetsky Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118481","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118481?lang=en_us&edition=fundamental","pubTime":"2025-12-20 06:27","pubTimestamp":1766183273,"startTime":"0","endTime":"0","summary":"David Linetsky, President, Network Solutions, reported a disposal of common shares of Phreesia Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phreesia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL6tFKf6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHR","BK4167"],"gpt_icon":0},{"id":"2592118488","title":"Phreesia Inc. Principal Accounting Officer Yvonne Hui Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118488","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118488?lang=en_us&edition=fundamental","pubTime":"2025-12-20 06:25","pubTimestamp":1766183158,"startTime":"0","endTime":"0","summary":"Yvonne Hui, Principal Accounting Officer of Phreesia Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phreesia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLbdR2gs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Phreesia Inc. Principal Accounting Officer Yvonne Hui Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHR","BK4167"],"gpt_icon":0},{"id":"2592118633","title":"Firefly Neuroscience Announces Private Placement of New Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2592118633","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592118633?lang=en_us&edition=fundamental","pubTime":"2025-12-20 06:15","pubTimestamp":1766182559,"startTime":"0","endTime":"0","summary":"Firefly Neuroscience Inc. announced that it has entered into a Warrants Cancellation and Exchange Agreement with certain investors, under which previously issued warrants from June 2025 will be exchanged for new warrants to purchase the company’s common stock. The transaction is being conducted as a private placement, relying on exemptions from registration under the Securities Act. If all new warrants are exercised, Firefly Neuroscience could receive gross proceeds of approximately $400,000, which the company plans to use for working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLb6D3q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","AIFF","BK4134"],"gpt_icon":0},{"id":"2592197161","title":"Veeva Systems Inc. Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Vipin Kondath","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197161","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592197161?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:03","pubTimestamp":1766178185,"startTime":"0","endTime":"0","summary":"Veeva Systems Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Vipin Kondath as the beneficial owner, serving as the company’s Chief Accounting Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL7VcyZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veeva Systems Inc. Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Vipin Kondath","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","BK4585","BK4588","BK4167","BK4613","VEEV","LU0289739699.SGD","LU1989764748.USD","LU0170899867.USD","LU0058720904.USD","BK4504","LU1989764664.SGD","BK4534","BK4528"],"gpt_icon":0},{"id":"2592862194","title":"HeartFlow (HTFL): Assessing a Rich Valuation After the Latest Share Price Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2592862194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592862194?lang=en_us&edition=fundamental","pubTime":"2025-12-20 01:12","pubTimestamp":1766164379,"startTime":"0","endTime":"0","summary":"HeartFlow (HTFL) has climbed about 9% in a day and 8% over the past week, an eye catching move for a relatively young medtech stock. Investors are asking whether this momentum is sustainable.\nSee our latest analysis for HeartFlow.\nThe latest surge comes after a choppy few months, with a 30 day share price return of 5.21% but a 90 day share price return still in negative territory, suggesting momentum is only just starting to rebuild.\nIf HeartFlow's recent move has your attention, it could be...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-htfl/heartflow/news/heartflow-htfl-assessing-a-rich-valuation-after-the-latest-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-htfl/heartflow/news/heartflow-htfl-assessing-a-rich-valuation-after-the-latest-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4167","DCF","HTFL"],"gpt_icon":0},{"id":"2592181405","title":"Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2592181405","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592181405?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:05","pubTimestamp":1766091900,"startTime":"0","endTime":"0","summary":"Reinforces Role of AI-Powered Quantitative Coronary Plaque AssessmentMOUNTAIN VIEW, Calif., Dec.  18, 2025  (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3208182/0/en/Heartflow-Plaque-Analysis-Now-Supported-by-Scientific-Statements-From-American-College-of-Cardiology-and-American-Heart-Association-for-Personalized-Management-of-Patients-with-Sus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AI","BK4587","AFG","CTA","HTFL","BK4117","BK4107","BK4167","BK4585","BK4588","BK4551","BK4023","BK4528","BK4543"],"gpt_icon":0},{"id":"2592018218","title":"Why Inspire Medical Systems (INSP) Is Down 15.6% After Medicare Fee Hike And New Lawsuits","url":"https://stock-news.laohu8.com/highlight/detail?id=2592018218","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592018218?lang=en_us&edition=fundamental","pubTime":"2025-12-19 04:21","pubTimestamp":1766089279,"startTime":"0","endTime":"0","summary":"In recent days, Inspire Medical Systems has faced renewed attention as regulators finalized a substantial future increase in Medicare facility fees for its sleep apnea procedure, while multiple law firms advanced securities class actions tied to the rollout of its Inspire V device.\nThis combination of richer long-term reimbursement and heightened legal and execution scrutiny creates a complex risk–reward backdrop for investors assessing Inspire’s path forward.\nNow we’ll explore how the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-insp/inspire-medical-systems/news/why-inspire-medical-systems-insp-is-down-156-after-medicare","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-insp/inspire-medical-systems/news/why-inspire-medical-systems-insp-is-down-156-after-medicare","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","LU2065731478.USD","INSP","BK4167"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4167","nameEN":"BK4167"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Health Care Technology(BK4167) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Health Care Technology,BK4167,Health Care Technology股票,Health Care Technology股票老虎,Health Care Technology股票老虎国际,Health Care Technology行情,Health Care Technology股票行情,Health Care Technology股价,Health Care Technology股市,Health Care Technology股票价格,Health Care Technology股票交易,Health Care Technology股票购买,Health Care Technology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Health Care Technology(BK4167) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction